 | • レポートコード：MRC2-11QY08398 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は経口抗凝固剤のグローバル市場について調査・分析したレポートです。種類別（PAI、LMWH、DTI、DFXa、VKA、その他）市場規模、用途別（VTE、ACS/MI、AF、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別経口抗凝固剤の競争状況、市場シェア ・世界の経口抗凝固剤市場：種類別市場規模 2015年-2020年（PAI、LMWH、DTI、DFXa、VKA、その他） ・世界の経口抗凝固剤市場：種類別市場規模予測 2021年-2026年（PAI、LMWH、DTI、DFXa、VKA、その他） ・世界の経口抗凝固剤市場：用途別市場規模 2015年-2020年（VTE、ACS/MI、AF、その他） ・世界の経口抗凝固剤市場：用途別市場規模予測 2021年-2026年（VTE、ACS/MI、AF、その他） ・北米の経口抗凝固剤市場分析：米国、カナダ ・ヨーロッパの経口抗凝固剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの経口抗凝固剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の経口抗凝固剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの経口抗凝固剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Bristol-Myers Squibb、Bayer、Johnson & Johnson、Aspen、Boehringer Ingelheim、Lilly、Daiichi Sankyo、Otsuka、AstraZeneca ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Oral Anticoagulants Market
The global Oral Anticoagulants market size is projected to reach US$ 15640 million by 2026, from US$ 14530 million in 2020, at a CAGR of 7.1%% during 2021-2026.
Global Oral Anticoagulants Scope and Market Size
Oral Anticoagulants market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Anticoagulants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oral Anticoagulants market is segmented into
PAI
LMWH
DTI
DFXa
VKA
Others
Segment by Application, the Oral Anticoagulants market is segmented into
VTE
ACS/MI
AF
Others
Regional and Country-level Analysis
The Oral Anticoagulants market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Anticoagulants market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Anticoagulants Market Share Analysis
Oral Anticoagulants market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Anticoagulants business, the date to enter into the Oral Anticoagulants market, Oral Anticoagulants product introduction, recent developments, etc.
The major vendors covered:
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson
Aspen
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
1 Study Coverage
1.1 Oral Anticoagulants Product Introduction
1.2 Market Segments
1.3 Key Oral Anticoagulants Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Anticoagulants Market Size Growth Rate by Type
1.4.2 PAI
1.4.3 LMWH
1.4.4 DTI
1.4.5 DFXa
1.4.6 VKA
1.4.7 Others
1.5 Market by Application
1.5.1 Global Oral Anticoagulants Market Size Growth Rate by Application
1.5.2 VTE
1.5.3 ACS/MI
1.5.4 AF
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oral Anticoagulants Market Size, Estimates and Forecasts
2.1.1 Global Oral Anticoagulants Revenue 2015-2026
2.1.2 Global Oral Anticoagulants Sales 2015-2026
2.2 Global Oral Anticoagulants, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oral Anticoagulants Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Anticoagulants Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oral Anticoagulants Competitor Landscape by Players
3.1 Oral Anticoagulants Sales by Manufacturers
3.1.1 Oral Anticoagulants Sales by Manufacturers (2015-2020)
3.1.2 Oral Anticoagulants Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Anticoagulants Revenue by Manufacturers
3.2.1 Oral Anticoagulants Revenue by Manufacturers (2015-2020)
3.2.2 Oral Anticoagulants Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Anticoagulants Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Anticoagulants Revenue in 2019
3.2.5 Global Oral Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Anticoagulants Price by Manufacturers
3.4 Oral Anticoagulants Manufacturing Base Distribution, Product Types
3.4.1 Oral Anticoagulants Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Anticoagulants Product Type
3.4.3 Date of International Manufacturers Enter into Oral Anticoagulants Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oral Anticoagulants Market Size by Type (2015-2020)
4.1.1 Global Oral Anticoagulants Sales by Type (2015-2020)
4.1.2 Global Oral Anticoagulants Revenue by Type (2015-2020)
4.1.3 Oral Anticoagulants Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Anticoagulants Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Anticoagulants Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Anticoagulants Revenue Forecast by Type (2021-2026)
4.2.3 Oral Anticoagulants Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Anticoagulants Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oral Anticoagulants Market Size by Application (2015-2020)
5.1.1 Global Oral Anticoagulants Sales by Application (2015-2020)
5.1.2 Global Oral Anticoagulants Revenue by Application (2015-2020)
5.1.3 Oral Anticoagulants Price by Application (2015-2020)
5.2 Oral Anticoagulants Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Anticoagulants Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Anticoagulants Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Anticoagulants Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oral Anticoagulants by Country
6.1.1 North America Oral Anticoagulants Sales by Country
6.1.2 North America Oral Anticoagulants Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Anticoagulants Market Facts & Figures by Type
6.3 North America Oral Anticoagulants Market Facts & Figures by Application
7 Europe
7.1 Europe Oral Anticoagulants by Country
7.1.1 Europe Oral Anticoagulants Sales by Country
7.1.2 Europe Oral Anticoagulants Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Anticoagulants Market Facts & Figures by Type
7.3 Europe Oral Anticoagulants Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oral Anticoagulants by Region
8.1.1 Asia Pacific Oral Anticoagulants Sales by Region
8.1.2 Asia Pacific Oral Anticoagulants Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Anticoagulants Market Facts & Figures by Type
8.3 Asia Pacific Oral Anticoagulants Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oral Anticoagulants by Country
9.1.1 Latin America Oral Anticoagulants Sales by Country
9.1.2 Latin America Oral Anticoagulants Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Anticoagulants Market Facts & Figures by Type
9.3 Central & South America Oral Anticoagulants Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oral Anticoagulants by Country
10.1.1 Middle East and Africa Oral Anticoagulants Sales by Country
10.1.2 Middle East and Africa Oral Anticoagulants Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Anticoagulants Market Facts & Figures by Type
10.3 Middle East and Africa Oral Anticoagulants Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Oral Anticoagulants Products Offered
11.1.5 Sanofi Related Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Description and Business Overview
11.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Oral Anticoagulants Products Offered
11.2.5 Bristol-Myers Squibb Related Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description and Business Overview
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Oral Anticoagulants Products Offered
11.3.5 Bayer Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Oral Anticoagulants Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Aspen
11.5.1 Aspen Corporation Information
11.5.2 Aspen Description and Business Overview
11.5.3 Aspen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Aspen Oral Anticoagulants Products Offered
11.5.5 Aspen Related Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Description and Business Overview
11.6.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Boehringer Ingelheim Oral Anticoagulants Products Offered
11.6.5 Boehringer Ingelheim Related Developments
11.7 Lilly
11.7.1 Lilly Corporation Information
11.7.2 Lilly Description and Business Overview
11.7.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Lilly Oral Anticoagulants Products Offered
11.7.5 Lilly Related Developments
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Corporation Information
11.8.2 Daiichi Sankyo Description and Business Overview
11.8.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Daiichi Sankyo Oral Anticoagulants Products Offered
11.8.5 Daiichi Sankyo Related Developments
11.9 Otsuka
11.9.1 Otsuka Corporation Information
11.9.2 Otsuka Description and Business Overview
11.9.3 Otsuka Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Otsuka Oral Anticoagulants Products Offered
11.9.5 Otsuka Related Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Description and Business Overview
11.10.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AstraZeneca Oral Anticoagulants Products Offered
11.10.5 AstraZeneca Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Oral Anticoagulants Products Offered
11.1.5 Sanofi Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oral Anticoagulants Market Estimates and Projections by Region
12.1.1 Global Oral Anticoagulants Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Anticoagulants Revenue Forecast by Regions 2021-2026
12.2 North America Oral Anticoagulants Market Size Forecast (2021-2026)
12.2.1 North America: Oral Anticoagulants Sales Forecast (2021-2026)
12.2.2 North America: Oral Anticoagulants Revenue Forecast (2021-2026)
12.2.3 North America: Oral Anticoagulants Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Anticoagulants Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Anticoagulants Sales Forecast (2021-2026)
12.3.2 Europe: Oral Anticoagulants Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Anticoagulants Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Anticoagulants Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Anticoagulants Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Anticoagulants Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Anticoagulants Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Anticoagulants Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Anticoagulants Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Anticoagulants Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Anticoagulants Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Anticoagulants Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Anticoagulants Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Anticoagulants Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Anticoagulants Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oral Anticoagulants Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Anticoagulants Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Oral Anticoagulants Market Segments
Table 2. Ranking of Global Top Oral Anticoagulants Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Anticoagulants Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of PAI
Table 5. Major Manufacturers of LMWH
Table 6. Major Manufacturers of DTI
Table 7. Major Manufacturers of DFXa
Table 8. Major Manufacturers of VKA
Table 9. Major Manufacturers of Others
Table 10. Global Oral Anticoagulants Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Oral Anticoagulants Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Oral Anticoagulants Sales by Regions 2015-2020 (K Units)
Table 13. Global Oral Anticoagulants Sales Market Share by Regions (2015-2020)
Table 14. Global Oral Anticoagulants Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Oral Anticoagulants Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Oral Anticoagulants Sales Share by Manufacturers (2015-2020)
Table 17. Global Oral Anticoagulants Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Oral Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Anticoagulants as of 2019)
Table 19. Oral Anticoagulants Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Oral Anticoagulants Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Oral Anticoagulants Price (2015-2020) (USD/Unit)
Table 22. Oral Anticoagulants Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Oral Anticoagulants Product Type
Table 24. Date of International Manufacturers Enter into Oral Anticoagulants Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Anticoagulants Sales by Type (2015-2020) (K Units)
Table 27. Global Oral Anticoagulants Sales Share by Type (2015-2020)
Table 28. Global Oral Anticoagulants Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Oral Anticoagulants Revenue Share by Type (2015-2020)
Table 30. Oral Anticoagulants Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Oral Anticoagulants Sales by Application (2015-2020) (K Units)
Table 32. Global Oral Anticoagulants Sales Share by Application (2015-2020)
Table 33. North America Oral Anticoagulants Sales by Country (2015-2020) (K Units)
Table 34. North America Oral Anticoagulants Sales Market Share by Country (2015-2020)
Table 35. North America Oral Anticoagulants Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Oral Anticoagulants Revenue Market Share by Country (2015-2020)
Table 37. North America Oral Anticoagulants Sales by Type (2015-2020) (K Units)
Table 38. North America Oral Anticoagulants Sales Market Share by Type (2015-2020)
Table 39. North America Oral Anticoagulants Sales by Application (2015-2020) (K Units)
Table 40. North America Oral Anticoagulants Sales Market Share by Application (2015-2020)
Table 41. Europe Oral Anticoagulants Sales by Country (2015-2020) (K Units)
Table 42. Europe Oral Anticoagulants Sales Market Share by Country (2015-2020)
Table 43. Europe Oral Anticoagulants Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Oral Anticoagulants Revenue Market Share by Country (2015-2020)
Table 45. Europe Oral Anticoagulants Sales by Type (2015-2020) (K Units)
Table 46. Europe Oral Anticoagulants Sales Market Share by Type (2015-2020)
Table 47. Europe Oral Anticoagulants Sales by Application (2015-2020) (K Units)
Table 48. Europe Oral Anticoagulants Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Oral Anticoagulants Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Oral Anticoagulants Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Oral Anticoagulants Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Oral Anticoagulants Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Oral Anticoagulants Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Oral Anticoagulants Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Oral Anticoagulants Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Oral Anticoagulants Sales Market Share by Application (2015-2020)
Table 57. Latin America Oral Anticoagulants Sales by Country (2015-2020) (K Units)
Table 58. Latin America Oral Anticoagulants Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Oral Anticoagulants Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Oral Anticoagulants Revenue Market Share by Country (2015-2020)
Table 61. Latin America Oral Anticoagulants Sales by Type (2015-2020) (K Units)
Table 62. Latin America Oral Anticoagulants Sales Market Share by Type (2015-2020)
Table 63. Latin America Oral Anticoagulants Sales by Application (2015-2020) (K Units)
Table 64. Latin America Oral Anticoagulants Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Oral Anticoagulants Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Oral Anticoagulants Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Oral Anticoagulants Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Oral Anticoagulants Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Oral Anticoagulants Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Oral Anticoagulants Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Oral Anticoagulants Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Oral Anticoagulants Sales Market Share by Application (2015-2020)
Table 73. Sanofi Corporation Information
Table 74. Sanofi Description and Major Businesses
Table 75. Sanofi Oral Anticoagulants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Sanofi Product
Table 77. Sanofi Recent Development
Table 78. Bristol-Myers Squibb Corporation Information
Table 79. Bristol-Myers Squibb Description and Major Businesses
Table 80. Bristol-Myers Squibb Oral Anticoagulants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Bristol-Myers Squibb Product
Table 82. Bristol-Myers Squibb Recent Development
Table 83. Bayer Corporation Information
Table 84. Bayer Description and Major Businesses
Table 85. Bayer Oral Anticoagulants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Bayer Product
Table 87. Bayer Recent Development
Table 88. Johnson & Johnson Corporation Information
Table 89. Johnson & Johnson Description and Major Businesses
Table 90. Johnson & Johnson Oral Anticoagulants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Recent Development
Table 93. Aspen Corporation Information
Table 94. Aspen Description and Major Businesses
Table 95. Aspen Oral Anticoagulants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Aspen Product
Table 97. Aspen Recent Development
Table 98. Boehringer Ingelheim Corporation Information
Table 99. Boehringer Ingelheim Description and Major Businesses
Table 100. Boehringer Ingelheim Oral Anticoagulants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Boehringer Ingelheim Product
Table 102. Boehringer Ingelheim Recent Development
Table 103. Lilly Corporation Information
Table 104. Lilly Description and Major Businesses
Table 105. Lilly Oral Anticoagulants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Lilly Product
Table 107. Lilly Recent Development
Table 108. Daiichi Sankyo Corporation Information
Table 109. Daiichi Sankyo Description and Major Businesses
Table 110. Daiichi Sankyo Oral Anticoagulants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Daiichi Sankyo Product
Table 112. Daiichi Sankyo Recent Development
Table 113. Otsuka Corporation Information
Table 114. Otsuka Description and Major Businesses
Table 115. Otsuka Oral Anticoagulants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Otsuka Product
Table 117. Otsuka Recent Development
Table 118. AstraZeneca Corporation Information
Table 119. AstraZeneca Description and Major Businesses
Table 120. AstraZeneca Oral Anticoagulants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. AstraZeneca Product
Table 122. AstraZeneca Recent Development
Table 123. Global Oral Anticoagulants Sales Forecast by Regions (2021-2026) (K Units)
Table 124. Global Oral Anticoagulants Sales Market Share Forecast by Regions (2021-2026)
Table 125. Global Oral Anticoagulants Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 126. Global Oral Anticoagulants Revenue Market Share Forecast by Regions (2021-2026)
Table 127. North America: Oral Anticoagulants Sales Forecast by Country (2021-2026) (K Units)
Table 128. North America: Oral Anticoagulants Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Europe: Oral Anticoagulants Sales Forecast by Country (2021-2026) (K Units)
Table 130. Europe: Oral Anticoagulants Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Asia Pacific: Oral Anticoagulants Sales Forecast by Region (2021-2026) (K Units)
Table 132. Asia Pacific: Oral Anticoagulants Revenue Forecast by Region (2021-2026) (US$ Million)
Table 133. Latin America: Oral Anticoagulants Sales Forecast by Country (2021-2026) (K Units)
Table 134. Latin America: Oral Anticoagulants Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Middle East and Africa: Oral Anticoagulants Sales Forecast by Country (2021-2026) (K Units)
Table 136. Middle East and Africa: Oral Anticoagulants Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Oral Anticoagulants Players
Table 141. Oral Anticoagulants Customers List
Table 142. Oral Anticoagulants Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Anticoagulants Product Picture
Figure 2. Global Oral Anticoagulants Sales Market Share by Type in 2020 & 2026
Figure 3. PAI Product Picture
Figure 4. LMWH Product Picture
Figure 5. DTI Product Picture
Figure 6. DFXa Product Picture
Figure 7. VKA Product Picture
Figure 8. Others Product Picture
Figure 9. Global Oral Anticoagulants Sales Market Share by Application in 2020 & 2026
Figure 10. VTE
Figure 11. ACS/MI
Figure 12. AF
Figure 13. Others
Figure 14. Oral Anticoagulants Report Years Considered
Figure 15. Global Oral Anticoagulants Market Size 2015-2026 (US$ Million)
Figure 16. Global Oral Anticoagulants Sales 2015-2026 (K Units)
Figure 17. Global Oral Anticoagulants Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Oral Anticoagulants Sales Market Share by Region (2015-2020)
Figure 19. Global Oral Anticoagulants Sales Market Share by Region in 2019
Figure 20. Global Oral Anticoagulants Revenue Market Share by Region (2015-2020)
Figure 21. Global Oral Anticoagulants Revenue Market Share by Region in 2019
Figure 22. Global Oral Anticoagulants Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Oral Anticoagulants Revenue in 2019
Figure 24. Oral Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Oral Anticoagulants Sales Market Share by Type (2015-2020)
Figure 26. Global Oral Anticoagulants Sales Market Share by Type in 2019
Figure 27. Global Oral Anticoagulants Revenue Market Share by Type (2015-2020)
Figure 28. Global Oral Anticoagulants Revenue Market Share by Type in 2019
Figure 29. Global Oral Anticoagulants Market Share by Price Range (2015-2020)
Figure 30. Global Oral Anticoagulants Sales Market Share by Application (2015-2020)
Figure 31. Global Oral Anticoagulants Sales Market Share by Application in 2019
Figure 32. Global Oral Anticoagulants Revenue Market Share by Application (2015-2020)
Figure 33. Global Oral Anticoagulants Revenue Market Share by Application in 2019
Figure 34. North America Oral Anticoagulants Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Oral Anticoagulants Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Oral Anticoagulants Sales Market Share by Country in 2019
Figure 37. North America Oral Anticoagulants Revenue Market Share by Country in 2019
Figure 38. U.S. Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Oral Anticoagulants Market Share by Type in 2019
Figure 43. North America Oral Anticoagulants Market Share by Application in 2019
Figure 44. Europe Oral Anticoagulants Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Oral Anticoagulants Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Oral Anticoagulants Sales Market Share by Country in 2019
Figure 47. Europe Oral Anticoagulants Revenue Market Share by Country in 2019
Figure 48. Germany Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Oral Anticoagulants Market Share by Type in 2019
Figure 59. Europe Oral Anticoagulants Market Share by Application in 2019
Figure 60. Asia Pacific Oral Anticoagulants Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Oral Anticoagulants Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Oral Anticoagulants Sales Market Share by Region in 2019
Figure 63. Asia Pacific Oral Anticoagulants Revenue Market Share by Region in 2019
Figure 64. China Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Oral Anticoagulants Market Share by Type in 2019
Figure 87. Asia Pacific Oral Anticoagulants Market Share by Application in 2019
Figure 88. Latin America Oral Anticoagulants Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Oral Anticoagulants Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Oral Anticoagulants Sales Market Share by Country in 2019
Figure 91. Latin America Oral Anticoagulants Revenue Market Share by Country in 2019
Figure 92. Mexico Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Oral Anticoagulants Market Share by Type in 2019
Figure 99. Latin America Oral Anticoagulants Market Share by Application in 2019
Figure 100. Middle East and Africa Oral Anticoagulants Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa Oral Anticoagulants Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Oral Anticoagulants Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Oral Anticoagulants Revenue Market Share by Country in 2019
Figure 104. Turkey Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Oral Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E Oral Anticoagulants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Oral Anticoagulants Market Share by Type in 2019
Figure 111. Middle East and Africa Oral Anticoagulants Market Share by Application in 2019
Figure 112. North America Oral Anticoagulants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America Oral Anticoagulants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Oral Anticoagulants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe Oral Anticoagulants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Oral Anticoagulants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific Oral Anticoagulants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Oral Anticoagulants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America Oral Anticoagulants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Oral Anticoagulants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa Oral Anticoagulants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
新規経口抗凝固剤（NOAC）の世界市場（～2026年） Market Analysis and Insights: Global Novel Oral AntiCoagulants (NOAC) Market The global Novel Oral AntiCoagulants (NOAC) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Novel Oral AntiCoagulants (NOAC) Scope and Market…- 抗凝固薬の世界市場（～2026年） Market Analysis and Insights: Global Anticoagulants Drug Market The global Anticoagulants Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anticoagulants Drug Scope and Market Size Anticoagulants Drug market is seg…
- 口腔粘膜炎の世界市場（～2026年） Mucositis occurs when cancer treatments break down the rapidly divided epithelial cells lining the gastro-intestinal tract (which goes from the mouth to the anus), leaving the mucosal tissue open to ulceration and infection. Mucosal tissue, also known as mucosa or the mucous membrane, lines all body…
- 口腔カンジダ症の世界市場（～2026年） Oral thrush occurs when a yeast infection develops on the inside of mouth and on tongue. This condition is also known as oral candidiasis, oropharyngeal candidiasis, or, simply, thrush. The Candida albicans fungus causes oral thrush. A small amount of this fungus normally lives in your mouth without…
- 経口血糖降下薬（OAD）治療の世界市場（～2026年） Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabet…